Disclosure
W., Epilepsia, P., Referência de Epilepsia
REFRACTORY EPILEPSY, BRAIN, COLON, EPILEPSY, EVENTS
J. Peltola has participated in clinical trials for Eisai, UCB, and Bial; received research grants from Eisai, Medtronic, UCB, and Livanova; received speaker honoraria from LivaNova, Eisai, Medtronic, Orion Pharma, and UCB; received support for travel to congresses from LivaNova, Eisai, Medtronic, and UCB; and participated in advisory boards for Arvelle, Novartis, LivaNova, Eisai, Medtronic, UCB, and GW Pharma. A.J. Colon received speaker honoraria from Medtronic. J. Pimentel received occasionally fees from Medtronic for speeches, travel meetings and collecting data for the MORE registry, and courses. V.A. Coenen received honoraria for talks from Boston Scientific, USA. He has received grants for clinical trials (IITs) from Boston Scientific, USA, and Medtronic, USA. He receives an ongoing collaborative grant from BrainLab (Munich, Germany). V.A. Coenen is scientific advisor for CereGate (Hamburg) and Cortec (Freiburg). A. Gil-Nagel received grants or honoraria as speaker or advisory board from Bial, Biocodex, Eisai, Stoke Therapeutics, GW Pharma, Esteve, UCB Pharma, Zogenix, and Arvelle Therapeutics. A. Gonçalves Ferreira declares Medtronic support to his participation in different scientific events including being member of the MORE Steering Committee. K. Lehtimäki received speaker or consultancy fees from Medtronic. P. Ryvlin has received speaker or consultant fees from UCB Pharma, GW Pharmaceutical, Eisai, Arvelle, Livanova, and Medtronic. R.S. Taylor is a paid consultant for Medtronic. However, he received no payment associated with preparation/contribution to this manuscript. L. Ackermans reports no disclosures relevant to the manuscript. J. Ardesch reports no disclosures relevant to the manuscript; she is a member of a data safety monitoring board, nonprofit. C. Bentes reports that the Reference Centre for Refractory Epilepsy from Hospital de Santa Maria Â–Centro Hospitalar Lisboa Norte received fees from Medtronic in January 2021 for the educational course: Curso Luso Brasileiro DBS em Epilepsia. M. Bosak received honoraria for publications for and participation in advisory meetings from Sanofi, honoraria for lectures, travel expenses, and conference fees from Sanofi, Adamed, Teva Pharmaceutical, Neuraxpharm, Glenmark, UCB Pharma, and Zentiva. J.G. Burneo is the Jack Cowin endowed chair in Epilepsy Research at Western University. C. Chamadoira, C.E. Elger, L. Erőss, D. Fabo, H. Faulkner, J. Gawlowicz, A. Gharabaghi, and M. Iacoangeli report no disclosures relevant to the manuscript. J. Janszky received consultation fees from Hungarian subsidiaries of UCB, Richter, and Gerot. Regarding this study, the author did not receive any corporate funding and receives research support from the Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002), NKFIH EFOP-3.6.2-16-2017-00008 government-based funds. S. Järvenpää received study grants from the Maire Taponen Foundation, Finnish Epilepsy Research Foundation, Finnish Medical Foundation, and Instrumentarium Science Foundation, none of which are relevant to the manuscript. E. Kaufmann has received speaker honoraria from Medtronic. K.H. Kho, E. Kumlien, H. Laufs, C. Lettieri, P. Linhares, S. Noachtar, A. Parrent, and E. Pataraia report no disclosures relevant to the manuscript. N.K. Patel reports no disclosures relevant to the manuscript. He is clinical director at Bioinduction Ltd. A.R. Peralta reports that Centro de Referência de Epilepsia Refractária, of which A.R. Peralta is a member, received speaker honoraria from Medtronic. A. Rácz received fees as a speaker from UCB Pharma. A. Rainha Campos received a travel grant and speaker honorarium from Medtronic. R. Rego received advisory honoraria from Medtronic. R.A. Ricciuti reports no disclosures relevant to the manuscript. S. Rona discloses compensation for data collection in the MORE study. R.P.W. Rouhl reports no disclosures relevant to the manuscript. A. Schulze-Bonhage has received research funding from BIAL, BMBF, DFG, EU, NIH, Precisis, and UNEEG. He has received honoraria for advice or lectures from Arvelle, BIAL, EISAI, GW, and UCB. R. Schuurman acts as consultant for Medtronic on educational matters. M. Sprengers, A. Sufianov, and Y. Temel report no disclosures relevant to the manuscript. T. Theys holds a learning chair Neuromodulation, an endowment from Medtronic. W. Van Paesschen, D. Van Roost, and R. Vaz report no disclosures relevant to the manuscript. K. Vonck has been funded by the Bijzonder Onderzoeksfonds (BOF) of Ghent University and received funding from the Geneeskundige Stichting Koningin Elisabeth (GSKE) for Neuroscience. K. Vonckt is also a consultant for Synergia Medical and Livanova and has received free devices for research studies in normal volunteers and preclinical studies from Cerbomed. L. Wagner and J. Zwemmer report no disclosures relevant to the manuscript. A. Abouihia was a Medtronic Employee at the time of performing the analyses and development of the manuscript. T.C. Brionne is a Medtronic Employee. F. Gielen is a Medtronic Employee. P.A.J.M. Boon received speaker and consultancy fees from LivaNova, Medtronic, UCB Pharma, and Eisai. Go to 